Human monoclonal anti-PD-L1 antibodies and methods of use

• 收藏
• 分享

专利权人:

Inc.;Dana-Farber Cancer Institute

发明人:

Marasco, Wayne A.,Sui, Jianhua

申请号：

AU2013326901

公开号：

AU2013326901A1

申请日:

2013.10.04

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

The present invention comprises human monoclonal antibodies that bind to PD-L1 (also known as programmed death ligand 1 or B7H1). Binding of the invented antibody to PD-L1 inhibits binding to its receptor, PD1 (programmed death 1), and ligand-mediated activities and can be used to treat cancer and chronic viral infections.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/